![]() | Up a level |
(2019) Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran. Plos Neglected Tropical Diseases. p. 18. ISSN 1935-2735
(2019) Host's immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: A case-control study of Th1 and Th2 pathways. International immunopharmacology. pp. 321-327. ISSN 1878-1705 (Electronic) 1567-5769 (Linking)